TNF- and cancer therapy-induced apoptosis: potentiation by inhibition of NF-kappaB
- PMID: 8864119
- DOI: 10.1126/science.274.5288.784
TNF- and cancer therapy-induced apoptosis: potentiation by inhibition of NF-kappaB
Abstract
Many cells are resistant to stimuli that can induce apoptosis, but the mechanisms involved are not fully understood. The activation of the transcription factor nuclear factor-kappa B (NF-kappaB) by tumor necrosis factor (TNF), ionizing radiation, or daunorubicin (a cancer chemotherapeutic compound), was found to protect from cell killing. Inhibition of NF-kappaB nuclear translocation enhanced apoptotic killing by these reagents but not by apoptotic stimuli that do not activate NF-kappaB. These results provide a mechanism of cellular resistance to killing by some apoptotic reagents, offer insight into a new role for NF-kappaB, and have potential for improvement of the efficacy of cancer therapies.
Comment in
-
Life-death balance within the cell.Science. 1996 Nov 1;274(5288):724. doi: 10.1126/science.274.5288.724. Science. 1996. PMID: 8966553 No abstract available.
-
Transcription factors, oncogenes, and apoptosis.Science. 1997 Apr 11;276(5310):185. doi: 10.1126/science.276.5310.181f. Science. 1997. PMID: 9132938 No abstract available.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
